A detailed history of Key Client Fiduciary Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Key Client Fiduciary Advisors, LLC holds 2,329 shares of NVS stock, worth $241,866. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,329
Previous 2,354 1.06%
Holding current value
$241,866
Previous $250,000 6.8%
% of portfolio
0.13%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$106.13 - $120.89 $2,653 - $3,022
-25 Reduced 1.06%
2,329 $267,000
Q2 2024

Jul 16, 2024

BUY
$92.57 - $107.37 $2,314 - $2,684
25 Added 1.07%
2,354 $250,000
Q1 2023

Apr 25, 2023

BUY
$80.03 - $92.81 $186,389 - $216,154
2,329 New
2,329 $214,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Key Client Fiduciary Advisors, LLC Portfolio

Follow Key Client Fiduciary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key Client Fiduciary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Key Client Fiduciary Advisors, LLC with notifications on news.